A Multi-Center, Continuation Trial of Belimumab (HGS1006, LymphoStat-B™)a Fully Human Monoclonal Anti-BLyS Antibody in Subjects With Systemic Lupus Erythematosus (SLE) Who Completed the Phase 3 Protocol HGS1006-C1056 or HGS1006-C1057
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00005024/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a long-term continuation study to provide continuing treatment to subjects with SLE.
提供机构：
Vivli
创建时间：
2019-11-19
